Overview of Current Progress in Immune Checkpoint Inhibitor Therapy for Advanced Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) remains to a common cause of tumor mortality worldwide and represents the most common type of lethal hepatic malignancy. The incidence of HCC is swiftly increasing in western countries and southeast Asia. Despite poor prognosis, traditional treatments for advanced HCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Xinlun, Wang, Shupeng, Niu, Chunyuan, Ji, Bai, Liu, Yahui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432969/
http://dx.doi.org/10.1177/1533033820947486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432969/
http://dx.doi.org/10.1177/1533033820947486

Ejemplares similares